DK0610078T3 - Cytotoksisk og antiviral forbindelse. - Google Patents

Cytotoksisk og antiviral forbindelse.

Info

Publication number
DK0610078T3
DK0610078T3 DK94300780.7T DK94300780T DK0610078T3 DK 0610078 T3 DK0610078 T3 DK 0610078T3 DK 94300780 T DK94300780 T DK 94300780T DK 0610078 T3 DK0610078 T3 DK 0610078T3
Authority
DK
Denmark
Prior art keywords
cytotoxic
antiviral compound
compound
kalahide
sacoglossan
Prior art date
Application number
DK94300780.7T
Other languages
English (en)
Inventor
Paul J Schauer
Dolores G Gravalos
Mark T Hamann
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Application granted granted Critical
Publication of DK0610078T3 publication Critical patent/DK0610078T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
DK94300780.7T 1993-02-03 1994-02-02 Cytotoksisk og antiviral forbindelse. DK0610078T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939302046A GB9302046D0 (en) 1993-02-03 1993-02-03 Antiumoral compound-v

Publications (1)

Publication Number Publication Date
DK0610078T3 true DK0610078T3 (da) 1997-10-20

Family

ID=10729727

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94300780.7T DK0610078T3 (da) 1993-02-03 1994-02-02 Cytotoksisk og antiviral forbindelse.

Country Status (11)

Country Link
EP (1) EP0610078B1 (da)
JP (1) JP3452628B2 (da)
AT (1) ATE151776T1 (da)
AU (1) AU677258B2 (da)
CA (1) CA2114859C (da)
DE (1) DE69402576T2 (da)
DK (1) DK0610078T3 (da)
ES (1) ES2102772T3 (da)
GB (1) GB9302046D0 (da)
GR (1) GR3024028T3 (da)
ZA (1) ZA94748B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0002952D0 (en) * 2000-02-09 2000-03-29 Pharma Mar Sa Process for producing kahalalide F compounds
AU1074902A (en) * 2000-10-31 2002-05-15 Pharma Mar Sa Kahalalide f
AU2002334203C1 (en) * 2001-10-19 2008-10-09 Pharma Mar, S.A. Kahalalide compounds for use in cancer therapy
GB0304367D0 (en) 2003-02-26 2003-04-02 Pharma Mar Sau Methods for treating psoriasis
CN100591691C (zh) * 2002-10-18 2010-02-24 马尔药品公司 新型抗肿瘤化合物
KR20110114690A (ko) * 2002-10-18 2011-10-19 파르마 마르 에스.에이.유. 4-메틸헥사노 카할라리드 f 화합물
US7507708B2 (en) 2003-02-26 2009-03-24 Pharma Mar, S.A.U. Antitumoral compounds
GB0321066D0 (en) 2003-09-09 2003-10-08 Pharma Mar Sau New antitumoral compounds
WO2009052379A2 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments
US20110015135A1 (en) * 2008-03-07 2011-01-20 Pharma Mar S.A. Antitumoral Treatments
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68903907T2 (de) * 1988-09-05 1993-06-09 Sankyo Co Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
US4986988A (en) * 1989-05-18 1991-01-22 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptides dolastatin 13 and dehydrodolastatin 13

Also Published As

Publication number Publication date
DE69402576D1 (de) 1997-05-22
JP3452628B2 (ja) 2003-09-29
ZA94748B (en) 1994-09-29
DE69402576T2 (de) 1997-10-02
AU5491194A (en) 1994-08-11
EP0610078B1 (en) 1997-04-16
CA2114859C (en) 2008-04-15
ATE151776T1 (de) 1997-05-15
GB9302046D0 (en) 1993-03-24
AU677258B2 (en) 1997-04-17
CA2114859A1 (en) 1994-08-04
GR3024028T3 (en) 1997-10-31
ES2102772T3 (es) 1997-08-01
JPH0770185A (ja) 1995-03-14
EP0610078A1 (en) 1994-08-10

Similar Documents

Publication Publication Date Title
IL94915A (en) Substituted quinazolinones and pharmaceutical compositions containing them
ATE269290T1 (de) Benzoylderivate
TW226375B (da)
FI905983A (fi) Aminosyraderivat.
DE69426904D1 (de) Phosphonat-Nukleotid Ester-Derivate
HUT67742A (en) Phosphono-oxymethyl-ethers of taxane derivatives
CA2075173A1 (en) Compounds and methods for inhibition of hiv and related viruses
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
IL94484A0 (en) Diarylstyrylquinoline diacids and pharmaceutical compositions containing them
GR1000118B (el) Συνθεσις 1,2-διοξετανων & ενδιαμεσαι ουσιαι δι αυτην.
TW280813B (da)
IL87421A0 (en) Pharmaceutical compositions containing 5-amino(or substituted amino)-1,2,3-triazoles
DK0610078T3 (da) Cytotoksisk og antiviral forbindelse.
DK0613687T3 (da) Anvendelse af pregnanderivat til behandling af tumorer
GR3022604T3 (en) Inhibitors of hiv protease useful for the treatment of aids.
DK638787D0 (da) Anthracyclinderivater, deres fremstilling og anvendelse
DK0418990T3 (da) 13-brom- og 13,14-dibrom-ergoliner, deres fremstilling og anvendelse i lægemidler
ES2053808T3 (es) Nuevos compuestos azolicos.
GR3020597T3 (en) Phospholipids for the treatment of multiple sclerosis
IT1262952B (it) Tetraalchilpiperidine, loro preparazione e loro impiego come stabilizzanti alla luce. (caso 153-5502)